Fair Value Calculator Fair Value Calculator
EN DE

1121 (1121) Fair Value & Analysis

Consumer Cyclical · Market cap HK$1.0B

1 1121 1121 · HK
PriceHK$0.5400
Fair ValueHK$0.2500
Upside-53.7%
Quality30/100
Evidence: Low Range HK$0.2300 – HK$0.2800

Fair value as of: Jul 2, 2026

From 3 valuation models · updated today

Share price −40.0% over the past month.

Price vs Fair Value (12 months)

HK$2.13 HK$0.4800 Fair Value HK$0.2500 Jun 2025 Jun 2026

12‑month range HK$0.4800 – HK$2.13 · fair‑value band HK$0.2300 – HK$0.2800 · the HK$0.5400 price screens above the HK$0.2500 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1121 (1121) currently trades at HK$0.5400, while our model-based Fair Value estimate is HK$0.2500 — implying the stock looks roughly 53.7% overvalued today. We read business quality at 30/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at HK$155M. Revenue declined 27.0% year over year. It earns a return on equity of -94.8%. Net debt stands at HK$144M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$155M
Revenue growth (YoY) -27.0%
Net margin -199%
Return on equity -94.8%
Free cash flow −HK$5.5M FY2025
Operating margin -161%
More key figures
EPS (TTM) HK$-0.0900
Net debt HK$144M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1121 reported revenue of HK$155M in FY2025 versus HK$314M in FY2021, a compound −16.1%/yr. Reported net income was −HK$308M in FY2025.

Revenue −16.1%/yr
FY21 HK$314M
FY22 HK$274M
FY23 HK$295M
FY24 HK$254M
FY25 HK$155M
Net income
FY21 HK$9.2M
FY22 −HK$167M
FY23 −HK$326M
FY24 −HK$277M
FY25 −HK$308M

Is 1121 fairly valued? → Check now

Similar stocks

6 more Footwear & Accessories stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
NIKE, Inc NKE €39.88 €32.06 -20%
adidas AG ADDYY $99.68 $63.37 -36%
ASICS Corporation ASCCY $26.56 $19.43 -27%
Deckers Outdoor Corporation DECK $105.57 $172.88 +64%
On Holding ONON $36.21 $20.28 -44%
Zhejiang China Commodities City Group 600415 ¥10.63 ¥18.58 +75%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 1121 (1121) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.2500 versus a price of HK$0.5400 — about −54% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 1121?
Our model-based fair value for 1121 is HK$0.2500 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.5400.
What is the quality score of 1121?
1121 has a Quality Score of 30/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 1121 (1121)?
1121 reported trailing-twelve-month revenue of about HK$155M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 1121?
The net profit margin of 1121 is about -198.5%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.